Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)

Market Cap	5.30B
Revenue (ttm)	1.47B
Net Income (ttm)	162.56M
Shares Out	190.18M
EPS (ttm)	0.85
PE Ratio	32.78
Forward PE	n/a
Dividend	0.50 (1.84%)
Ex-Dividend Date	Nov 28, 2025

Volume	1,206,500
Average Volume	2,730,608
Open	27.15
Previous Close	27.35
Day's Range	27.10 - 27.42
52-Week Range	17.25 - 41.47
Beta	0.10
RSI	46.79
Earnings Date	Apr 28, 2026

About SHE:003020

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethylphenidate HCL, dioctyl sulfosuccinate sodium salt, and DMSA. It also provides intermediate products, such as sodium paeonolsilate, methy2-(2,3-dichlor...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 1,456
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 003020

Financial Performance

In 2024, SHE:003020's revenue was 1.52 billion, a decrease of -20.11% compared to the previous year's 1.90 billion. Earnings were 160.60 million, a decrease of -29.15%.